NASDAQ:GTHX

G1 Therapeutics Earning Date

USA |NASDAQ |USD

GTHX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-1.00 $-0.94 $-0.31
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $5.18M $6.60M $26.60M

G1 Therapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

GTHX Earnings Date & History Chart

GTHX Earnings & Revenue Forecast

GTHX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-1.02 $-1.13 $-0.84
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-3.64 $-3.79 $-3.35
Dec 2022 8 $-3.69 $-4.23 $-3.27

GTHX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.99 $-0.95 $-0.92
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-3.63 $-3.53 $-3.49
Dec 2022 0 / 0 $-3.63 $-3.51 $-3.43

GTHX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 7 $8.06M $5.00M $14.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $31.34M $14.23M $42.82M
Dec 2022 8 $56.66M $29.29M $72.90M

GTHX Earnings Date & Revenue History

GTHX Earnings History

|
Show More
Show More

GTHX Revenue History

|
Show More
Show More

G1 Therapeutics Next Earnings Date & Report

GTHX Next Earnings Date & Report Preview: Sep 2021 (FQ)

GTHX's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 7 analysts, the average EPS estimation for G1 Therapeutics's next quarterly earnings is $-1.00, with a low EPS estimation of $-1.07, and a high estimation of $-0.92.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.99, the last 2 month trend is $-0.96, and the 3 month trend is $-0.95.

Based on 7 analysts, the average revenue estimation is $5.18M, with a low revenue estimation of $4.00M, and a high estimation of $8.00M.

G1 Therapeutics Previous Earnings Dates & Reports

GTHX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

G1 Therapeutics's previous earnings date was Aug 4, 2021 for its fiscal quarter ended Jun 30, 2021.

GTHX's earnings per share (EPS) was $-0.94, beating the consensus analysts forecast of $-0.98 by 3.72%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 44.62%, and lower than the same period a year before (Jun 2020) by 13.25%.

Revenues were $6.60M, better than the forecast of $6.60M by 0.00%, down by -53.55% from the previous quarter , and up by 208.60% from the same period last year.

The company reported a net income of $-39.42M.

Free cash flow for the quarter was $-36.49M , compared to $-26.88M last quarter and $-28.85M a year before.

GTHX ended the quarter with $37.42M in total debt, a decrease of -0.25% compared to the previous quarter, and an increase of 34.46% compared to the same quarter a year before.

GTHX Previous Earnings Date & Report Recap: Dec 2020 (FY)

G1 Therapeutics's previous annual earnings date was Feb 24, 2021 for its fiscal year ended Dec 31, 2020.

GTHX's earnings per share (EPS) was $-2.63, beating the consensus analysts forecast of $-2.85 by -7.72% , and higher than the previous year's EPS (Dec 2019) by -19.33%.

Revenues were $45.28M.

The company reported a net income of $-99.25M.

G1 Therapeutics reported a free cash flow of $-83.74M for its fiscal year, compared to $-102.29M a year ago.

The company ended the fiscal year with $27.76M in total debt, an increase of 171.68% compared to the previous year.